The Diabetes theme has 10 member stock(s) today, with an average return of -0.8%. The leading stock is 녹십자엠에스 (+3.7%, trading value 1,254,206,398).
Chronic disease treatment and management market, drawing attention due to synergistic growth with obesity treatments (GLP-1) and the adoption of advanced medical devices such as Continuous Glucose Monitors (CGM).
| Stock | Price | Return | Trading Value |
|---|---|---|---|
| 녹십자엠에스 | 3,220 | +3.7% | 1,254,206,398 |
| 현대약품 | 9,990 | +1.7% | 91,954,453,550 |
| 삼진제약 | 18,550 | +0.6% | 334,786,470 |
| 윈팩 | 2,065 | +0.5% | 81,084,312 |
| 제일약품 | 10,020 | -0.8% | 124,929,760 |
| 동운아나텍 | 26,950 | -1.6% | 2,015,501,225 |
| 아이센스 | 16,260 | -1.8% | 582,820,565 |
| 안트로젠 | 14,940 | -2.4% | 304,476,545 |
| 압타바이오 | 6,400 | -3.0% | 103,958,205 |
| 펩트론 | 139,100 | -4.7% | 16,492,239,650 |
This page's data is for reference only and is not investment advice. Actual market data may differ.